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1. Introduction
The roles of natural killer (NK)T cells in intestinal immunity have not been sufficiently
investigated. The bowel possesses its own unique mucosal immune system, the gut-associated
lymphoepithelial tract (GALT). In this review, we focused on CD1d-independent invariant
type NKT (iNKT) cells as modulators of GALT. iNKT cells have a restricted invariant T-cell
receptor (TCR) Vα24 chain paired with Vβ11 chain. In addition to T helper (Th)1 cytokines,
such as IFN-γ, iNKT cells can produce anti-inflammatory Th2 cytokines, such as interleukin
(IL)-4.
Although invariant NKT cells are rare in normal small-intestine mucosa, they have been
observed in intestinal allografts during rejection. Infiltrating iNKT cells release IL-4 and IL-5,
Th2-related cytokines that antagonize the Th1 responses that induce acute cellular rejection.
Also, iNKT cells form an immunological barrier against parasite infection. We found that CD1d
+cells are actually localized in the lamina propria of the villi in the human intestine and they
may present the antigen for the recruited iNKT cells.
On the other hand, a small number of invariant NKT cells are resident in the normal colorectal
mucosa. iNKT cells are involved in defense against colorectal tumor progression and meta‐
stasis through the apoptosis-inducing molecule Fas ligand (FasL). Their numbers increase
markedly in colorectal carcinomas. Increased iNKT cell infiltration in colorectal carcinomas is
an independent favorable prognostic factor. iNKT cells probably play an important role in the
pathogenesis of ulcerative colitis.
Thus, iNKT cells are modulators of bowel mucosal immunity.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Background
2.1. Gut-associated lymphoepithelial tract (GALT)
The bowel possesses a distinct mucosal immune system, known as the gut-associated lym‐
phoepithelial tract (GALT), which is comprised of high endothelial venules (HEVs) located in
the inter-follicular region (IFR) around the Peyer’s patches (PPs). GALT-associated immunity
involves an exquisite balance between activation and suppression mediated through the
release of cytokines [1] (Figure 1). The GALT contains the largest collection of lymphocytes in
the body. Physiologic and barrier functions of GALT against bacterial infection are associated
with mucosal surfaces and are essential; therefore, only limited damage can be tolerated. The
mucosa is continuously exposed to a vast array of antigens, necessitating the distinguishing
of self from non-self/infectious antigens. Infectious agents, malignant tumors such as adeno‐
carcinomas, and immune and inflammatory bowel diseases of the gut all contribute to
morbidity and mortality.
The lymphocytes in the bowel are believed to play pivotal roles in bowel immunity. Two types
of lymphocytes are found in the bowel: intra-epithelial lymphocytes (IELs) and lamina propria
(LP) lymphocytes (LPLs). In addition, the PPs are comprised of B cells and T cells, unique
lymphocyte subsets that interact with M epithelial cells. Antigens are taken up by the PPs
through the M-cell layer, inducing an immune reaction (Figure 1).
In addition, lymphocytes from the GALT circulate in the common mucosal immune system,
including the mesenteric lymph nodes.
LPLs play important roles in immune homeostasis. Although these cells function in mucosal
defense against pathogens, they ignore non-pathogenic bacteria and foods, a phenomenon
known as oral tolerance. LPLs also play a supporting role in barrier defenses and are involved
in the pathogenesis of inflammatory intestinal diseases. At the onset of Crohn’s disease,
mucosal T cells appear to mount a typical T helper (Th)1 response that resembles an acute
infectious process, but this response is lost with progression to later stages of Crohn’s disease.
Such polarization of bowel cytokines is believed to be responsible for inflammatory bowel
diseases (IBD).
2.2. Natural killer T cells
NKT cells are associated with both innate and adaptive immunity due to their ability to interact
with a broad spectrum of antigens.
NKT cells are currently classified into three types classical NKT cells (non-classical NKT cells);
and NKT-like cells, or CD1d-independent NK1.1+T cells [2]. Classical NKT cells express CD161
[2, 3]. Human classical NKT cells express an invariant TCR, Vα24, whereas mouse NKT cells
express TCRVα14 [4, 5]. In contrast, the T-cell receptor V regions expressed by non-classical
NKT cells and NKT-like cells are highly diverse. CD56-NKT cells are believed to function as
effector or regulatory cells in innate immunity.
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2.3. Invariant natural killer T (iNKT) cells
Among these NK cells, iNKT cells have a very restricted TCR repertoire, which in human
peripheral blood consists of an invariant Vα24-Ja18 chain (formerly Vα24-JaQ) paired with a
Vβ11 chain [4, 6]. Therefore, this classical type is termed “invariant” NKT (iNKT) cells (Figure
2). Human iNKT cells can be activated by glycolipid antigens such as beta-galactosylceramide
and iGb3, which are presented by CD1d expressed on dendritic cells [7]. When activated, iNKT
cells immediately produce pro-inflammatory Th1 cytokines such as IFN-γ and tumor necrosis
factor (TNF)-α as well as anti-inflammatory Th2 cytokines, such as IL-4, IL-10, and IL-13. Thus,
iNKT cells are capable of bidirectional differentiation, which is probably directed by the
immunological environment.
iNKT cells are localized primarily in the thymus, bone marrow, liver, and spleen, and they are
rare in the lymph nodes [8]. Bannai et al. [9] reported that mouse colon contains a considerable
number of NKT cells. More recently, O’Keeffe et al. reported that T cells expressing CD161+(a
phenotypic marker of NK cells) are the major natural killer receptor–positive cell population
in the intestine. Although the intestines harbor a diverse array of NKT cells, iNKT cells are
rare in the small intestine [10].
Figure 1. GALT and iNKT cells. M cells and mucosal epithelial cells cover the lamina propria of the bowel. HEV: high
endothelial venules, Th1 & Th2, helper T cell Type 1 & 2. iNKT cells relate to the development of B cells and T cells in
the lamina propria by release of cytokines such as IL-4, IL-5, IFN-γ.
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Figure 2. T, invariant natural killer (NK)T, and NK cells. The phenotypic surface antigens are shown. The T cell receptor
(TCR) is variable in T cells; the TCR on the invariant type of human NKT cells is restricted to the Vα24β11 type. NK cells
do not carry a TCR and express CD161, CD56, or CD57 NK markers, which are also expressed by NKT cells.
2.4. Invariant natural killer T (iNKT) cells in diseases
iNKT cells have been implicated as playing roles in infection control [11, 12], inflammatory
bowel diseases [13], abortion [14], transplantation tolerance [15, 16], suppression of autoim‐
mune diseases [17-20], psoriasis and atopic dermatitis [21], and the regulation of allergic
disorders [22, 23]. iNKT cells have the potential to activate or suppresses immune system by
release of variable cytokines including IFN-γ, IL-4, IL-10, and IL-17.
Moreover, a number of reports have suggested that iNKT cells play protective as well as
tolerogenic roles in tumor immunity [24-29]. In addition, infiltration of iNKT cells is a prog‐
nostic indicator for colorectal cancer metastasis [29].
3. iNKT cells in the small intestine
3.1. Mucosal immunity of the small intestine
The mucosal immune system of the small intestine is unique. Mucosal barrier damage and
inflammation have been associated with high levels of flagellin protein in the lumen. One of
the roles of intestinal immunity is defense against pathogens within the bacterial flora. The
mucosa is covered by mucin, which is one of the central determinants of gut immune specificity
and immune tolerance.
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The LP, located beneath the mucosa, includes various types of immune cells that form the
GALT. The PP is a predominant immune apparatus that is covered by M cells and is capable
of controlling mucosal immunity. In addition to the lymph apparatus and lymphocytes, the
intestinal immune system contains dendritic cells (DCs) that interact with goblet cells. Mucus
sensing enhances DC tolerogenic functions, including the release of TGF-β and suppressive
IL-10, which are factors that induce FoxP3+regulatory T (Treg) cell production. Populations of
CD3+TCR-γδ cells are also observed [29]. CD56+NK cells are classically viewed as lymphocytes
that provide innate immunity against virus-infected cells and tumor cells through the release
of cytolytic mediators and IFN-γ.
3.2. iNKT cells in the small intestine and coeliac disease
Intestinal iNKT cells are rare in the normal status [10], but small population is observed in the
villi of the small intestine [30]. Although they have not been considered as minor participants
in the control of GALT. However, iNKT cells are found to decrease in the celiac disease without
affecting development of classical T cells. Coeliac disease is one of the autoimmune disorders
of the small intestine. This disease occurs in genetically predisposed people of all ages from
middle infancy. Symptoms include pain, chronic constipation and diarrhea in children.
Diagnoses are occasionally being made in asymptomatic persons in the screening examination.
Importantly, coeliac disease is not allergic disease, but caused by a reaction to a gluten protein
in wheat. When the small intestine is exposed to gluten, the tissue transglutaminase modifies
the protein, and the GALT autoimmunologically cross-reacts with the small intestinal tissue,
causing an inflammatory reaction. As a result, villous atrophy is observed histologically and
endoscopically. The absorption of nutrients is significantly affected. The effective treatment is
a lifelong gluten-free diet. The deficiency of Vα24+ cells in coeliac disease was independent of
age, gluten status of diet or duration of gluten‐free diet. Probably, T cells are selected by
glycolipids on CD1d expressing CD4+CD8+thymocytes [30].
3.3. Small-intestine allograft immunity
3.3.1. Background on intestinal transplantation
Intestinal transplantation is a commonly accepted standard therapy for patients with irrever‐
sible parenteral nutrition complications associated with short-bowel syndrome, [31-33],
Hirschsprung and related diseases, chronic idiopathic intestinal pseudo-obstruction syn‐
drome, and megacystis-microcolon-intestinal hypoperistalsis syndrome [34, 35]. Acute
cellular rejection (ACR) remains the major cause of intestinal graft failure after transplantation.
Diagnosis of ACR requires detection by histopathologic evaluation [35-38] as well as clinical
examination and laboratory data [38].
3.3.2. Histologic criteria for diagnosis of ACR of small-intestine transplants
Pathologists have diagnosed acute rejection based on the finding of crypt apoptosis in the
intestinal mucosa upon histologic examination of the graft [36-38], rather than lymphocytic
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infiltrates. The number of apoptotic bodies is certainly augmented during the acute rejection;
however, the mechanism underlying this phenomenon has not been determined.
Mucosal damage cannot be prevented once crypt apoptosis has become evident [38]. It is
possible that apoptosis of crypt cells is induced by direct attack by cytotoxic T-lymphocytes
(CTLs), but such a finding has not been reported. Therefore, it remains unclear whether CTL
infiltration is necessary for ACR. Humoral factors may also play a role in crypt apoptosis.
Although there are reports describing T-cell apoptosis in the intestine in ongoing ACR, its
clinical significance has not been determined [39]. T cells interact with Fas on other T cells to
induce their apoptosis [40]. The apoptotic T cells are then phagocytosed by macrophages in
the small-intestine allografts. Similar findings in a liver allograft has been reported by us [41].
Thus, these phagocytic findings may be common to various allografts in ACR. The phagocy‐
tosing macrophages form granulomas. Furthermore, apoptotic bodies are also positive for Fas,
which is a surface antigen of activated T lymphocytes. Treatment with a steroid pulse signif‐
icantly diminishes the apoptotic and phagocytotic responses that are indicative of ACR [42].
Although it is possible that both recipient and donor lymphocytes interact with each other via
Fas and FasL molecules to induce apoptosis, a study using animal models reported that TNF-
α (rather than interaction between Fas and FasL) is the primary factor for induction of
lymphocytic apoptosis [39].
3.3.3. iNKT cells infiltrate during acute rejection of the allograft
Using systematic immunohistochemical analysis of an intestinal allograft, we assessed the
behavior of iNKT cells during acute rejection of the intestinal allograft [38]. In practice, the
diagnosis of intestinal rejection is difficult, particularly due to the complicated interactions
between lymphocytes and other immunological cells resulting from the transient coexistence
of donor-derived and recipient-derived cells in the graft.
iNKT cells are transiently recruited to the intestinal LP (Figure 3), but immunosuppressive
therapy significantly decreased iNKT cells in number (Figure 4&5). The infiltrating intestinal
iNKT cells have the potential to produce IL-4, which antagonizes IFN-γ and contributes to the
development of Th2 cells. Higher levels of IL-4 prior to and shortly after kidney transplantation
have been reported, and IL-4 may have a protective effect on renal graft survival [43]. Indeed,
iNKT cells have been implicated in tolerance in experimental mouse models, in induction of
chimerism in allogenic cardiac transplant models [44], and in acceptance of rat-islet xenografts
in mice [16]. IFN-γ production remains low relative to normal donor intestine and does not
change during the course of ACR development. Therefore, infiltration of iNKT cells implies
that they are involved in the response to rejection. Asaoka et al. reported the activation of CTLs
in granzyme B/perforin-mediated graft injury [45]. Therefore, release of Th2-related cytokines
by iNKT cells may antagonize this activation.
3.3.4. PPs and iNKT cells in small-intestine allografts
After transplantation, recipient-derived T cells traffic into the allograft across the HEVs located
in the IFR around the PPs. Therefore, the PP serves as the interface through which the allograft
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encounters recipient-derived cells. Although, few studies have examined injury to the PPs
during rejection, histology of PP showed the hyperplastic change of PP with an increase in
expression of CD20, a mature B cell marker at the onset of rejection (Figure 6).
PPs consist primarily of B cells, T cells and DCs. In general, B cells carry out a variety of immune
functions, including immunoglobulin production, cytokine release, antigen presentation,
regulation of DC activity, and participation in the induction of immune tolerance [46]. A large
number of T cells and B cells are present in the intestinal LP. The majority of T cells in the LP
express the TCRαβ, and the proportion of CD8+T cells to CD4+T cells ranges from 2:1 to 3:1.
The production of IL-4 and IL-5 by CD4+T cells in the LP promotes IgA production in the
intestinal tract. Furthermore, CD8+T cells in the LP are responsible for damage by recognizing
and activating macrophages. The primary antibodies secreted into the intestinal tract mucus
are IgA. A number of IgA-producing cells distribute in the LP, and IgA molecules that are
secreted into the intestinal tract are transported to the gut luminal side by binding to multi‐
meric antibody receptors that are retained on the intestinal epithelial cells.
 
(A) (B) (C) (D) 
Figure 3. Immunohistochemistry of iNKT cells: (A) TCRVα24 (left) and (B) TCRVβ11 stained cells in brown. Fluorescent
immunostaining of TCRVα24 (C), IL-4 (D).
Figure 4. Time-course analyses using allograft tissues showed a significant decrease in the number of iNKT cells after
immunosuppressant administration. The left photo illustrates the significant decrease in the number of iNKT cells after
administration. Immunostaining of iNKT cells at the onset of ACR (left) and 48 hrs after administration of steroids
(middle) is shown. Brown cells are iNKT cells in the allograft mucosa. Counterstaining was performed using methyl-
green. iNKT cells underwent apoptosis in the graft. The right photo below shows TUNEL-positive (yellow) iNKT cells.
Non-iNKT cells were stained red (phycoerythrin-labeled). This photo is the serial section of the left section [39].
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Both B-1 and B-2 cells produce IgA. B-2 cells are derived from PP B cells and exhibit a CD23+,
CD11b-, CD5-, and CD19low phenotype. Follicular B cells in the PPs are stimulated by antigen
in the intestinal lumen and differentiate from IgM+to IgA+cells by class switching. IgA+cells
in the PPs circulate throughout the body via the thoracic duct and differentiate into IgA-
producing cells by the effect of IL-6 produced by intestinal epithelial cells. B-1 cells, in contrast,
are derived from B cells of the abdominal cavity and exhibit a CD19+, CD23-, and CD11b+
(B-1a, CD5+; B-1b, CD5-) phenotype. Whereas B-2 cell-derived secretory IgA recognizes
foreign antigens with high affinity, B-1 cell-derived secretory IgA recognizes common bacterial
phosphorylcholine, lipopolysaccharide, and self-antigens with low affinity.
3.3.5. Cytokine production in the intestinal allograft
Cytokine measurements have suggested that the levels of a variety of cytokines are increased
at the onset of ACR and that TNF-α contributes to mucosal damage in graft-versus-host disease
[47]. The graph below shows the production of various cytokines in graft mucosal tissues
without PPs before transplantation, during ACR, and 72 hrs after administration of a steroid
pulse. The data show that production of both IL-4 and IL-5 increase significantly relative to
other cytokines in the allograft tissue during ACR, suggesting that ACR involves hypercyto‐
kinemia (Figure 7)[38].
Figure 5. Distribution of iNKT cells in six intestinal allografts. The count of iNKT cells was evaluated by their number
per 1mm2 of a section. PP, Peyer’s patch; IFR, inter-follicular region; SED, mucosal sub-epithelial dome; LPV, lamina
propria of the villi. Individual bars of intact, onset, and post-administration display the TCRVα24+T cell counts in the
intact mucosa, in the mucosa with rejection, and in the mucosa 48 hours after >30mg of steroid administration (post-
steroid therapy).
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Figure 7. Cytokine concentration in the histologic normal allograft, at the onset of acute cellular rejection (ACR) and
72 hours after steroid pulse. Error bars indicate S.D. [38].
3.3.6. Activated iNKT cells may damage the small-intestine allograft by release of IL-4/IL-5
Cytokine production by iNKT cells was observed in grafts and total cytokine concentration in
sampled tissue was measured. Graphs show plots of the concentrations of IL-4, IL-5, IL-10,
and IFN-γ (pg/mg in graft tissue) versus the mean number of IL-4+-, IL-5+-, IFN-γ+-, and
IL-10+-iNKT cells (per 10 high-power foci [HPF]). Linear regression lines and correlation
coefficient (R2) values are also shown (Figure 8).
Figure 6. Peyer’s patch (PP) hyperplasia in acute rejection of small intestinal allograft. Left photo shows an H&E
stained hyperplastic PP in the graft at the onset of rejection. Right photo shows the CD20+ stained hyperplastic PP.
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Figure 8. Regression analysis of cytokine concentration and counts of iNKT cells. IL-4 and IL-5 iNKT cell count correlate
with total concentration of IL-4 and IL-5 in the graft.
It is likely that as yet unknown humoral factors recruit iNKT cells to the graft mucosa in order
to suppress allograft rejection. iNKT cells have the ability to release IL-4 and antagonize Th1
and CTL responses [48]. However, because the released IL-4 and IL-5 may damage the allograft
via eosinophilic enteritis, appropriate immunosuppression is necessary for recovery. We
therefore investigated humoral rejection. iNKT cells may modulate such ACR via the release
of cytokines.
3.4. NKT cells in intestinal inflammation caused by parasites
iNKT cells can also modulate mucosal immunity through the release of IL-4 and IL-5 in
response to parasite infection. A previous study showed that NKT cells play a critical role in
the lethal ileitis induced in C57BL/6 mice after infection with Toxoplasma gondii [49]. This
intestinal inflammation is caused by overproduction of IFN-γ by iNKT cells in the LP. This
detrimental activity of iNKT cells can be blocked by treatment with alpha-galactosylceramide,
which induces a shift in cytokine production by iNKT cells toward a Th2 profile. iNKT cells
participate in the clearance of parasites by shifting the cytokine profile toward a Th1 pattern.
Another study using CD1d-deficient mice lacking iNKT cells showed that iNKT cells are
critical for the elimination of T. gondii [50]. Thus, iNKT cells may form an immunological barrier
against parasite infection.
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4. iNKT cells in large-intestine immunity
4.1. NKT cells in the large intestine
Unlike the small intestine, a considerable number of NKT cells reside intra-epithelially in the
colon of mice [9]. CD161+T cells are the major natural killer receptor-positive cell population
in the intestine [10]. On the other hand, few reports have been published regarding human
NKT cells, particularly iNKT cells, in the normal and neoplastic colon.
Our previous study was the first report the presence of TCRVα24+ iNKT cells in the colon [29].
In that study, a small number of Vα24+NKT cells were observed in the normal colorectal
mucosa (2.6 ± 3.7 cells/5 HPF), unlike the small intestine, which contained few resident NKT
cells.
4.2. Intra-colorectal tumor iNKT cells
Furthermore, we investigated intra-tumor TCRVα24-positive cells in 103 primary colorectal
carcinoma samples [29]. The observation that intra-tumor Vα24+T cells invariably coexpress
TCRVβ11 and other NK cell markers indicates that they are iNKT cells. The density of iNKT
cells in colorectal carcinomas increased significantly. iNKT cells were actually found in the
luminal space of tumor-infiltrating vessels. iNKT cells could migrate from the peripheral blood
to the tumors. A higher fraction of iNKT cells express the activation marker CD69 in colorectal
carcinomas than in normal mucosa, and these cells are probably involved in local cytotoxicity
against tumor cells through secretion of IFN-γ and apoptosis-inducing molecules such as FasL,
perforin, and granzyme B. In this way, iNKT cells may play a role in the primary defense
against colorectal carcinoma by induction of tumor cell death. Alternatively, the increase in
the number of NKT cells in tumors may represent a surrogate marker of antitumor activity.
Coca et al. reported that colorectal carcinomas with a higher degree of CD57+NK cell infiltra‐
tion have better prognosis [51]. Because the CD57+cell population includes NKT cells, the
present observation agrees in part with their conclusion. Another interesting feature of our
study was the finding that iNKT cells play a role in the inhibition of lymph node metastasis of
colorectal carcinomas [29]. Although iNKT cells are normally rare in lymph nodes, a large
number of these cells appear in the metastasis-free swollen lymph nodes of colorectal carci‐
noma patients. The precise mechanism through which iNKT cells inhibit lymph node meta‐
stasis remains unclear. Activated iNKT cells may migrate to regional lymph nodes, where they
may prevent metastasis by inducing apoptosis of the colorectal carcinoma cells. A recent study
reported that chemokine CXCL16 suppresses liver metastasis of colorectal cancer via aug‐
mentation of tumor-infiltrating iNKT cells in a murine model [52].
Patients with a higher degree of intra-tumor NKT-cell infiltration show significantly higher
rates of overall and disease-free survival. This is consistent with the fact that these patients
exhibit much less lymph node metastasis. The degree of NKT cell infiltration in tumors was
evaluated as low degree (<7 NKT cells/five x400 foci) or high degree (≥7 NKT cells/ five x400
foci). The number of iNKT cells increased markedly in colorectal carcinomas, and a majority
of these cells showed a phenotype of activation expressing FasL or CD69. A higher degree of
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iNKT cell infiltration correlated with lower lymph node metastasis (P=0.042). Patients with a
high degree of iNKT cell infiltration showed higher overall (P=0.018) as well as disease-free
(P=0.0006) survival rates. Intra-tumor iNKT cell infiltration was an independent prognostic
factor for overall (P=0.033) and disease-free (P=0.0064) survival. A higher degree of iNKT
infiltration in colorectal carcinomas is therefore an independent indicator of a favorable
prognosis [29] (Figure 9).
Figure 9. iNKT cells and apoptosis of tumor cells. FasL, perforin, and granzyme B are apoptosis-inducing molecules.
iNKT cells may contribute to apoptosis of the cancer cell by release of these molecules and prevent the metastasis to
the lymph node.
4.3. IBD and iNKT cells
The relevance of iNKT cells in IBD has also been examined. iNKT cells probably play an
important role in the pathogenesis of ulcerative colitis [13, 22, 52]. Although our immunohis‐
tochemical data indicated that iNKT cells certainly contribute to inflammation, their influence
is limited in the initial phase of IBD (data not shown). Several reports have indicated that iNKT
cells secrete abundant amounts of IL-4 upon activation [53]. There has been a report that
oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-
producing NK-T cells [54].
Important data regarding the role of iNKT cells in IBD were recently reported [31]. iNKT cells
accumulate in the colonic lamina propria in germ-free mice, resulting in increased morbidity
in models of IBD as compared with specific pathogen-free mice. The chemokine ligand
CXCL16 is associated with an increase in the number of mucosal iNKT cells and consequently
an increase in susceptibility to tissue inflammation. Age-sensitive contact with commensal
microbes is critical for establishing mucosal iNKT cell tolerance to later environmental
exposures. Microbial exposure early in life elicits long-lasting effects on iNKT cells, and in the
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absence of early exposure, exposure later in life to factors that stimulate these cells may induce
an auto-inflammatory response.
In a related report, a profound loss of CD56 expression by all lymphocyte populations was
noted in the coeliac gut. Adult coeliac disease expanded populations of CD3+TCRγδ cells and
decreased populations of NK, NKT, and iNKT cells [30].
4.4. Microbial infection and iNKT cells
The relevance of iNKT cells against microbial infection has also been examined. CD1d-
dependent antigen presentation and microbial killing by iNKT cells are critical for host defense
[55]. The host defense against microbial infection depends upon cargo trafficking into lyso‐
somes. The mechanism has been reported [56]. Arf-like GTPase Arl8b is one of the critical
regulators of cargo delivery to lysosomes. The formation of CD1 antigen-presenting complexes
in lysosomes and phagosome-lysosome fusion depends on Arl8b. Subsequently the delivered




The quantitative morphometry method to study iNKT cells was applied (Figure 10). Multi‐
variate morphometric analysis images were obtained by microscopy (PROVIS-AX80; Olym‐
pus, Tokyo, Japan) and saved as TIF files. Data were analyzed using CELAVIEW software
(Olympus), with individual cell signals expressed in terms of relative fluorescent unit.
Morphometric data were displayed according to stained area and circularity. Individual cells
were represented by the pixel intensities of the nucleus and cytoplasm. Data sets for individual
cells on a single slide were represented by two-dimensional scatter plots based on flow
cytometry. Gated cells were further analyzed using antibodies for surface antigens. Plots were
further gated according to fluorescence intensity, size, and circularity on the scattergram.
Circularity was calculated based on the Heywood circularity factor using the following
formula:
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where the perimeter (P) of individual cells was divided by the circumference of a circle with
the same area (A), with the real circle factor being equivalent to 1.0. As the boundary of a binary
image is composed of discrete pixels, IMAQ Vision (National Instruments Corporation,
Austin, TX, USA) was used to sub-sample the boundary [21, 39]. The scheme of quantitative
morphometry is shown below.
Lymphocytes are oval or circular and the circulatory factor is nearly to 1.0. Therefore, the
subjects of which circulatory factor is nearly to to 1.0 is gated for subsequent analysis using
immunostaining. iNKT cells were actually gated for subsequent analysis using antibodies for
CD56 and TCRVα24. In the first gating, the area was also analyzed [42] (Figure 10).
 
Figure 10. A scheme of two dimensional plots of the morphometric analysis for analysis of surface antigens CD56 and
TCRVα24 on the iNKT cells. The gating shown in the left graph shows an example of selection of the analyzed lympho‐
cytes for analysis of the surface antigens shown in the right graph. The similarity to the circle is evaluated by the circu‐
latory factor near 1.0. The right figures the factor values of various shapes.
5.2. Immunohistochemistry
The fluorescent staining method for iNKT cells was as reported using the CSA system (DAKO,
Gostrup, Denmark). Frozen section samples and paraffin embedded specimens were used. For
primary reagents, we used monoclonal antibody C15 (TCRVα24; Immunotech SA, Marseilles,
France). Antibodies against CD3, CD4 and CD8 were purchased from DAKO, and DAB
staining was performed for signal visualization. Negative controls for primary antibodies were
IgG1, IG2a and IgG2b (Cat No. X0931, X0943 and X0944; DAKO) [29, 38].
6. Conclusion
The mucosa is exposed to an extremely wide variety of antigens in food, and iNKT cells within
the mucosa are responsible for mounting immune responses to these antigens. The cytokines
released during these responses may damage the small intestine. In the case of small-intestine
transplantation, the response of iNKT cells during ACR indicates that iNKT cells may be
recruited to the transplant to repress rejection. iNKT cells probably contribute to the suppres‐
sion of ACR by releasing IL-4, an antagonist of IFN-γ. On the other hand, iNKT cells normally
reside within the large intestine, where they also play a pivotal role in immunity. iNKT cells
can be activated to express apoptosis-inducing molecules and may induce cytolysis of tumor
cells. Thus, iNKT cells have two roles; they can upregulate or downregulate the mucosal
Immune Response Activation240
immune response through the release of opposite-acting cytokines. iNKT cells thus play a
pivotal role in modulating mucosal immunity in the intestine.
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